🔓 Unlock the full profile of Sreedhar Sappidi (Daicel Chiral Technologies (India) Pvt Ltd), including verified contact details, financial insights, and professional associations.
See Sreedhar Sappidi Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: sre*****@dai******.com
Mobile: 64128*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Sreedhar Sappidi founded NEXST Cell and Analytical Solutions Pvt Ltd, taking on the role of Founder and Director starting August 1, 2023, indicating a strong entrepreneurial initiative in the biotechnology sector.
- Previously served as Director of Peptides & Biologics at Daicel Chiral Technologies India Pvt Ltd from April 2021 until August 2023, overseeing critical operations and strategic developments in the peptides and biologics segment.
- Held the position of Associate Director for Biologics at Daicel Chiral Technologies India Pvt Ltd from December 2019 to April 2021, contributing significantly to advancements in biologics through innovative strategies and leadership.
- In a prior role as Senior Manager & Head of Biopharma at Vimta Labs Ltd from August 2015 to November 2019, was responsible for managing biopharmaceutical projects and leading research initiatives that enhanced the company’s service offerings.
- Also worked as Team Lead for Analytical R&D at Nagarjuna Innovation Centre from May 2014 to July 2015, where the focus was on developing analytical methods and methodologies to support R&D projects.
- Served as Manager of Analytical Development at Zenotech Laboratories from February 2012 to March 2014, leading efforts in analytical method development that contributed to the company's product development pipelines.
- Worked as a Consultant in Biotech at Virchow Biotech from October 2010 to October 2011, providing expert advice on biotechnology projects and helping navigate challenges in biopharmaceutical development.
- Commenced career at Intas Pharmaceuticals Limited as Scientist in Biocharacterization from April 2004 to August 2010, focusing on biocharacterization techniques that are essential for the development of biopharmaceutical products.